Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-31

Clinical Trial Update: Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Vitamin B6 and Magnesium in patients with Autism Spectrum Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin B6 and Magnesium

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Autism Spectrum Disorder | Phase 2 | Status: UNKNOWN